Skip to main content

Headline Roundup October 17th, 2017

Drug Czar Nominee Withdraws

Summary from the AllSides News Team

Congressman Tom Marino (R-PA) is withdrawing from consideration for the job of Drug Czar, following reports that he played a key role in passing a bill that weakened the federal government's authority to stop companies from distributing opioids.

Featured Coverage of this Story

Drug czar nominee withdraws after report he backed Big Pharma opioid bill
Drug czar nominee withdraws after report he backed Big Pharma opioid bill

The Week - News

News

President Trump announced Tuesday that Rep. Tom Marino (R-Pa.) has withdrawn his name from consideration for the head of the Office of National Drug Control Policy. "Tom is a fine man and a great congressman," Trump tweeted while sharing the news. On Sunday night, 60 Minutes and The Washington Post reported that Marino had worked for two years to push through a bill promoted and apparently written by the pharmaceutical industry that stripped the Drug Enforcement Administration of its biggest tool to fight prescription opioids entering the black market.

Open on The Week - News
Trump: Drug Czar Nominee, Rep. Marino, Withdrawing His Name - Here's Why
Trump: Drug Czar Nominee, Rep. Marino, Withdrawing His Name - Here's Why

CBN

News

President Donald Trump says the Pennsylvania congressman he chose to be the nation's drug czar is withdrawing from consideration for the job.

Open on CBN
Trump says drug czar nominee Tom Marino is withdrawing after Washington Post/’60 minutes’ investigation
Trump says drug czar nominee Tom Marino is withdrawing after Washington Post/’60 minutes’ investigation

Washington Post

News

President Trump said Tuesday that his nominee to be the nation's drug czar is withdrawing from consideration for the job. Rep. Tom Marino (R-Pa.) was under fire in the wake of revelations in a Washington Post/"60 Minutes” investigation that the lawmaker helped steer legislation in Congress making it harder to act against giant drug companies.

Open on Washington Post

More headline roundups

More News about Politics on AllSides

News from the Left

News from the Center

News from the Right